Tumour invasion and trophoblastic invasion share the same biochemical mediators: the matrix metalloproteinases (MMP) and their inhibitors. In contrast to tumour invasion of a host tissue, trophoblastic invasion during implantation and placentation is stringently controlled both in tissue localization and developmental stage. The factors responsible for these important regulatory processes are unknown, but in-vitro studies point to endometrial cytokines and growth factors as possible candidates. Here we examined the possibility that interleukin-6 (IL-6), a trophoblastic and endometrial cytokine, represents such a regulatory factor. Purified first trimester cytotrophoblastic cells (CTB) were cultured for 4 days in presence or absence of increasing concentrations of IL-6. MMP-2 and MMP-9 bioactivity (zymography) and immunoactivity were measured in the culture supernatants together with total human chorionic gonadotrophin (HCG), fetal fibronectin (FFN) and leptin. IL-6 did not change the cytotrophoblastic secretion of FFN or total HCG. In contrast, this cytokine induced a dose-dependent stimulation of the leptin secretion and increased the activity, but not the immunoreactivity, of MMP-9 and MMP-2. These results indicate that IL-6 could be considered as an endometriotrophoblastic regulator of cytotrophoblastic gelatinases.
Introduction
positioned at the feto-maternal interphase to suggest a modulatory role for this cytokine in trophoblast invasion. In haemochorial mammals, e.g. humans, massive trophoblast IL-6 is a multifunctional protein that plays important roles invasion is required for blastocyst implantation and plain host defence, acute phase reactions, immune responses and centation (Cross et al., 1994; Bischof and Campana, 1996) .
haematopoiesis. It has a four helix-bundle type tertiary structure The transiently invasive properties of trophoblastic cells are found in several other cytokines, e.g. LIF, granulocyte colony related to their capacity of secreting proteolytic enzymes stimulating factor and interleukin-11 (Bazan, 1990) . IL-6 exerts such as the matrix metalloproteinases (MMP) and the serine its activity through binding to a high affinity receptor complex proteinases. Gelatinase B is also called MMP-9 and is considconsisting of two membrane proteins: an 80 kDa IL-6-binding ered to be the rate-limiting factor in extracellular matrix receptor protein (Yamasaki et al., 1988) and a 130 kDa signalremodelling that occurs in the endometrium during trophotransducing protein (gp 130, Hibi et al., 1990) . It is interesting blastic invasion (Librach et al., 1991; Shimonovitz et al., to note that gp 130 is also associated with the LIF receptor 1994; Bischof et al., 1995a) . In contrast to tumour invasion (Gearing et al., 1991) . of a host tissue, trophoblastic invasion is stringently controlled IL-6 mRNA and protein have been localized in human both in location (it is limited to the endometrium and the endometrium where their expression was maximal during proximal myometrium) and in developmental stage (it ends the mid-secretory phase, thus at the time of implantation by about mid-gestation). The factors responsible for these (Tabibzadeh et al., 1995; Vandermolen and Gu, 1996) . Furtherimportant regulatory processes are unknown but in-vitro studies more, IL-6 secretion by endometrial stromal cells is enhanced point to endometrial cytokines and growth factors as possible by interferon-γ (Nasu et al., 1998) . In first trimester trophocandidates. Cytokines, e.g. transforming growth factor β blasts, IL-6 protein (Jauniaux et al., 1996) and mRNA (TGFβ; Graham and Lala, 1991) , leukaemia inhibitory factor (Stephanou et al., 1995) are present in both the cytotropho-(LIF; Bischof et al., 1995b) , epidermal growth factors (EGF; blastic cells (CTB) and the syncytiotrophoblast (STB). It Bass et al., 1994) , tumour necrosis factor (TNF; Meisser et al., must be noted that the expression of this cytokine decreases 1999), interleukin-1β (IL-1β; Simón et al., 1994a; significantly during differentiation of CTB into STB (Jauniaux et al., 1999) and insulin-like growth factor binding protein-1 et al., 1996) and that IL-6 concentrations are higher in decidual (IGFBP-1; Bischof et al., 1998) have been described as than in placental tissue (Jauniaux et al., 1996) . IL-6R and gp potential regulators of trophoblastic invasion. There is no 130 have been immunolocalized in endometrial epithelial cells reason to suppose that other cytokines are not involved in this (Tabibzadeh et al., 1995) and gp 130 mRNA has been detected in first and third trimester decidua and trophoblast (Kojima regulatory process. Indeed, interleukin-6 (IL-6) is suitably by a commercially available enzyme immunoassay (DRG Instruments, et al., 1995) as well as in human blastocysts (Sharkey et al., CIS-Medipro, Vernier, Switzerland) with a sensitivity of 0.2 ng/ml 1995). Thus IL-6 and its receptor proteins are present simultanand an inter-assay coefficient of variation of Ͻ7%. Total cell proteins eously on maternal and fetal tissues during implantation and were measured in the cell lysate with the Bio-Rad protein assay placentation. These observations prompted us to examine the according to the manufacturer's instructions and using bovine serum potential role of IL-6 on several parameters involved in albumin as the standard (Bio-Rad, München, Germany).
the invasive behaviour of CTB particularly MMP and fetal fibronectin (FFN) since these reflect matrix degradation and Statistical analysis deposition respectively. We also examined the effect of IL-6
To evaluate the effects of IL-6 on the different trophoblastic paraon trophoblastic leptin secretion since leptin is secreted by meters, the individual values were transformed into values per mg CTB and up-regulated by IL-1 . analyses were performed by analysis of variance using the StatView 4.5 program on the Power Macintosh 7100/66 computer and P values corrected for small sample size.
Materials and methods

Preparation of cytotrophoblastic cells (CTB) and culture
Results conditions CTB were isolated, purified and cultured as previously described
The effects described below were similar on days 2 and 4 of (Bischof et al., 1991) . Briefly, trophoblastic villi obtained from culture in the presence of IL-6. As described in the Materials induced abortions (6-12 weeks of pregnancy) were digested by and methods section, the production rate/day was calculated trypsin. CTB were separated from blood cells and syncytia on a for each parameter, taking into account the day 2 and day discontinuous Percoll gradient and the contaminating leukocytes 4 results. conditions (without IL-6), CTB secreted 2.9 ϩ 1.6 ng/day/ containing 2 mmol/l L-glutamine, 4.2 mmol/l magnesium sulphate, 2.5 mmol/l HEPES, 1% gentamycin, 1% Amphoptericin-B, 2ϫ105cells of leptin (mean ϩ SD). Concentrations of IL-6 of 100 µg/ml streptomycin (Grünenthal, Stolberg, Germany) and 0.5-10 ng/ml significantly stimulated MMP-9 activity (Figure 100 U/ml penicillin (Hoechst-Pharma, Zürich, Switzerland) in pres-1D, P ϭ 0.0064 to P ϭ 0.0017 respectively) but not MMP-9 ence of 10% FCS (Life Technologies). The next morning (day 0), immunoreactivity. Similarly, IL-6 significantly increased the medium was changed to serum-free DMEM and the cells were activity of proMMP-2 ( Figure 1F , P ϭ 0.0015 to P Ͻ 0.0008 incubated in the presence or the absence of increasing concentrations for concentrations of IL-6 from 0.1-10 ng/ml), the activity of of IL-6 (0.1-10 ng/ml; R&D Systems, Bühlmann, Basle, Switzerland).
MMP-2 (Figure1G, P ϭ 0.0007 and P ϭ 0.012 for 0.5 and 1 ng/ Incubation was performed under a 5% CO 2 and 95% air atmosphere ml of IL-6) but was without effects on the immunoreactivity of in a humidified incubator at 37°C. Medium was harvested on days 2 MMP-2. and 4 and the culture was stopped on day 4. The supernatants from days 2 and 4 were divided into aliquots and stored at -20°C until assayed. The cells were lysed with 200 µl Triton X-100 (25% in Discussion water) and stored at -20°C for total cell protein measurements.
Under our experimental conditions with primary trophoblastic cells, IL-6 remains without effects on HCG secretion. This is
Gelatinolytic assays
in contrast to previously published data showing a marked Zymography was performed as previously described (Martelli et al., stimulation of HCG by IL-6 via its own receptor (Nishino 1993). Zymograms were scanned in an 'Apple Onescanner' and the surface of the digestion bands measured by the NIH Image 1.60 et al., 1998) . This discrepancy might be due to the fact that program on a Power Macintosh 7100/66 computer. All zymograms these authors incubated IL-6 with primary CTB for only 2.5 h were evaluated using the same pre-set standards with a coefficient of whereas under our procedure, IL-6 remained in contact with variation of 18.6%. the cells for 2-4 days. This last protocol might have favoured an internalization of the IL-6R leading to a lack of effects.
Hormone and protein assays
Another possible explanation could be that IL-6 stimulates Total HCG (HCG ϩ free β-HCG) was measured in the supernatants HCG release (as measured by Nishino et al., 1998) , rather by a microparticle enzyme immunoassay with a sensitivity of than HCG synthesis, as measured in our experiments.
1 mIU/ml and a coefficient of variation of 3.6% (Abbott, Abbott
The obese gene product, leptin, a 167 amino acid peptide Park, IL, USA). FFN was measured by a commercially available (Zhang et al., 1994) , has provided a potential link between enzyme immunoassay with a sensitivity of 50 ng/ml and a coefficient food intake, energy balance and reproductive events (Chehab of variation of 7.5% (Adeza Biochemical, Sunnyvale, CA, USA).
et al., 1996) . A well-recognized site of leptin production is MMP-2 and MMP-9 immunoreactivities (MMP-2i and MMP-9i) were the adipocyte. Consequently, the amount of body fat appears measured in the supernatants using our own enzyme immunoassays as described elsewhere (Meisser et al., 1999) . Leptin was measured as the strongest determinant of plasma leptin values. Recently ( Hardie et al., 1997; Schubring et al., 1997) , it was demonthese data together, one could speculate that IL-6 activates trophoblastic metalloproteinases either through an increased strated that circulating leptin values were elevated during pregnancy, reaching a peak during the second trimester. Howsecretion of leptin or a mechanism independent of leptin secretion. IL-6 has been shown to enhance the invasiveness ever, fat deposition during pregnancy or pregnancy-induced endocrine changes could hardly explain such dramatic changes of head and neck cancer cell lines in vitro (Nishino et al., 1998) and of human ovarian cancer cell lines (Obata et al., implying that the feto-placental unit could be another important source of leptin (Masuzaki et al., 1997) . Here we show that 1997). However, in both models, IL-6 did not affect MMP-2 and MMP-9 activation (Mann et al., 1995; Obata et al., 1997) . leptin is indeed secreted by primary cytotrophoblast and that this secretion is stimulated by IL-6. It is interesting to note in
The contrasting effects of IL-6 on cancer cells and CTB is probably due to the nature of transformed and non-transthis respect that leptin and IL-6 share structural similarities and that the full-length leptin receptor has IL-6 signalling formed cells. Since LIF and IL-6 share the same signal transducer (gp 130, capabilities (Baumann et al., 1996; Tartaglia 1997) . The crossreactivity with IL-6 in the leptin assay has not been tested by Gearing et al., 1991) one would expect IL-6 and LIF to act in a similar way on trophoblastic cells. This is, however, not the the manufacturer but it is probably insignificant since rat leptin, which is closer to human leptin than IL-6, has a crosscase since we have shown that LIF, in contrast to IL-6, exerts potent inhibitory effects on trophoblastic MMP-2 and reactivity Ͻ0.2%. This IL-6 signalling capability might explain our recent results that recombinant human leptin activates MMP-9 (Bischof et al., 1995b) . More research is necessary into the molecular mechanisms governing signal transduction MMP-2 and MMP-9 in our primary trophoblastic cell cultures (M.Castellucci, R.De Matteis, A. Meisser et al., unpublished from the LIF and the IL-6 receptors. observations).
In the present study, IL-6 induced the activation of tropho-
